ArteFill

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2011
02420062011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
As we enter the new era of medicine in which cost becomes as important as outcomes, clinicians struggling to treat patients… (More)
  • table 1
Is this relevant?
2010
2010
At the risk of being considered as having a ‘‘hidden agenda’’ and being a ‘‘naysayer,’’ I focus on some important issues and… (More)
Is this relevant?
2009
2009
ArteFill is a novel, third-generation polymethylmethacrylate (PMMA) injectable filler with unique properties. When compared with… (More)
  • figure 1
Is this relevant?
2009
2009
After more than 25 years of research and development, in October 2006 ArteFill® became the first and only permanent injectable… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 2
  • figure 5
Is this relevant?
2009
2009
Patients ask for procedures with long-lasting effects. ArteFill is the first permanent injectable approved in 2006 by the FDA for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2007
2007
BACKGROUND A novel soft tissue filler composed of polymethylmethacrylate (PMMA) microspheres suspended in a collagen gel matrix… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Two new collagen-based lidocaine-containing dermal fillers, ArteSense/ArteFill (Artes Medical, San Diego, CA) and Evolence… (More)
Is this relevant?
2006
2006
The technical and physiologic shortcomings associated with prior generations of polymethylmethacrylate (PMMA) dermal fillers have… (More)
Is this relevant?
2006
2006
ArteFill, the successor product to Artecoll, is an injectable wrinkle filler composed of polymethylmethacrylate microspheres and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2006
2006
The ideal soft-tissue filler for wrinkles and skin defects should be safe, biocompatible, resistant to phagocytosis, persist and… (More)
Is this relevant?